Dry eye, sleep quality, and mood status in glaucoma patients receiving prostaglandin monotherapy were comparable with those in non-glaucoma subjects.
Shugyoku RaMasahiko AyakiKenya YukiKazuo TsubotaKazuno NegishiPublished in: PloS one (2017)
Our results were comparable between glaucoma patients on prostaglandin monotherapy and non-glaucoma subjects for dry eye-related clinical manifestations, sleep quality, and mood status.
Keyphrases
- sleep quality
- depressive symptoms
- optic nerve
- physical activity
- end stage renal disease
- ejection fraction
- cataract surgery
- newly diagnosed
- combination therapy
- chronic kidney disease
- open label
- randomized controlled trial
- bipolar disorder
- patient reported outcomes
- clinical trial
- patient reported
- optical coherence tomography